Celgene Corp. v. Canada (Attorney General) , 2011 SCC 1 ; [2011] 1 S.C.R. 3, Celgene Corp. v. Canada (Attorney General), 2011 SCC 1, 2011 SCC 1 (2011)

Docket Number: 33579

Linked as:

Extract

Celgene Corp. v. Canada (Attorney General) , 2011 SCC 1 ; [2011] 1 S.C.R. 3, Celgene Corp. v. Canada (Attorney General), 2011 SCC 1, 2011 SCC 1 (2011)

SUPREME COURT OF CANADA

Citation: Celgene Corp. v. Canada (Attorney General),

2011 SCC 1, [2011] 1 S.C.R. 3

Date: 20110120

Docket: 33579

Between:

Celgene Corporation

Appellant and

Attorney General of Canada

Respondent

Coram: McLachlin C.J. and Binnie, LeBel, Deschamps, Fish, Abella, Charron, Rothstein and Cromwell JJ.

Reasons for Judgment:

(paras. 1 to 35)

Abella J. (McLachlin C.J. and Binnie, LeBel, Deschamps, Fish, Charron, Rothstein and Cromwell JJ. concurring)

Celgene Corp. v. Canada (Attorney General), 2011 SCC 1, [2011] 1 S.C.R. 3

Celgene Corporation Appellant v.

Attorney General of Canada Respondent

Indexed as: Celgene Corp. v. Canada (Attorney General)

2011 SCC 1

File No.: 33579.

2010: November 10; 2011: January 20.

Present: McLachlin C.J. and Binnie, LeBel, Deschamps, Fish, Abella, Charron, Rothstein and Cromwell JJ.

on appeal from the federal court of appeal

Legislation -- Statutory interpretation -- Scope of the Patented Medicine Prices Review Board's price-regulating and remedial authority -- Meaning of "sold in any market in Canada" -- Whether concept should be interpreted in accordance with commercial law principles or be responsive to surrounding legislative context and purpose -- Patent Act, R.S.C. 1985, c. P-4, ss. 80(1)(b), 83(1), 85.

Administrative law -- Judicial review -- Standard of review -- Reasonableness of Patented Medicine Prices Review Board Board's interpretation of its enabling legislation -- Patent Act, R.S.C. 1985, c. P-4...

See the full content of this document